Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)

Detalhes bibliográficos
Autor(a) principal: Dourado, Marília
Data de Publicação: 2005
Outros Autores: Bento, Joana, Mesquita, Luis, Marques, Alcide, Vale-Pereira, Sofia, Sarmento-Ribeiro, Ana Bela, Mota-Pinto, Anabela
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/20228
https://doi.org/10.1016/s0873-2159(15)30495-5
Resumo: Sarcoidosis is a systemic disease of unknown aetiology, morphologically characterized by well-formed epithelioid granulomas, which show little or no central necrosis. These may be present in any organ or tissue. The lung is the most frequently and prominently involved target. The granuloma is often very sharply demarcated from the adjacent tissue and is surrounded by a mantle of lymphocytes, which mediate lysis of target cells by various mechanisms, including exocytosis of lytic proteins, perforins and granzymes. Sarcoidosis laboratorial diagnosis is usually made by SACE and Lisozyme dosages. The granzymes A and B could be two other markers of the disease, since the sarcoidosis granuloma is rich in cytotoxic and NK cells. An ELISA Kit was used to measure Granzyme A and B in serum of a normal control group (NC) (n=30), and in two groups with lung pathology: one without sarcoidosis, disease control (DC) (n=21) and other with sarcoidosis (S) (n=11). Our results showed that SACE activity is significantly augmented in S group comparing with NC and DC, respectively: 82,6+/-32,7/31,9+/-17,8 - p=0,00017 and 82,6+/-32,7/31,9+/-17,8 - p=0,00024. Lisozyme activity is significantly augmented in S and DC groups comparing with NC. Granzyme B showed a significant decrease in DC and S groups comparing with NC. Granzyme A showed a significant decrease between S/NC groups. Our results suggest that the decrease of Granzyme A and B in sarcoidotic patients could be related to an ineffective inflammatory local response related to the formation of sarcoidosis granulomas. More studies are needed, particularly in BAL.
id RCAP_d48eeacbcdad3e3978a119a655630110
oai_identifier_str oai:estudogeral.uc.pt:10316/20228
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)Granzymes A and B in pulmonary sarcoidosis (experimental study)GranzimasSarcoidoseSarcoidosis is a systemic disease of unknown aetiology, morphologically characterized by well-formed epithelioid granulomas, which show little or no central necrosis. These may be present in any organ or tissue. The lung is the most frequently and prominently involved target. The granuloma is often very sharply demarcated from the adjacent tissue and is surrounded by a mantle of lymphocytes, which mediate lysis of target cells by various mechanisms, including exocytosis of lytic proteins, perforins and granzymes. Sarcoidosis laboratorial diagnosis is usually made by SACE and Lisozyme dosages. The granzymes A and B could be two other markers of the disease, since the sarcoidosis granuloma is rich in cytotoxic and NK cells. An ELISA Kit was used to measure Granzyme A and B in serum of a normal control group (NC) (n=30), and in two groups with lung pathology: one without sarcoidosis, disease control (DC) (n=21) and other with sarcoidosis (S) (n=11). Our results showed that SACE activity is significantly augmented in S group comparing with NC and DC, respectively: 82,6+/-32,7/31,9+/-17,8 - p=0,00017 and 82,6+/-32,7/31,9+/-17,8 - p=0,00024. Lisozyme activity is significantly augmented in S and DC groups comparing with NC. Granzyme B showed a significant decrease in DC and S groups comparing with NC. Granzyme A showed a significant decrease between S/NC groups. Our results suggest that the decrease of Granzyme A and B in sarcoidotic patients could be related to an ineffective inflammatory local response related to the formation of sarcoidosis granulomas. More studies are needed, particularly in BAL.2005info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/20228http://hdl.handle.net/10316/20228https://doi.org/10.1016/s0873-2159(15)30495-5porDourado, MaríliaBento, JoanaMesquita, LuisMarques, AlcideVale-Pereira, SofiaSarmento-Ribeiro, Ana BelaMota-Pinto, Anabelainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2021-10-25T10:55:28Zoai:estudogeral.uc.pt:10316/20228Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:43:44.682041Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
Granzymes A and B in pulmonary sarcoidosis (experimental study)
title Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
spellingShingle Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
Dourado, Marília
Granzimas
Sarcoidose
title_short Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
title_full Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
title_fullStr Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
title_full_unstemmed Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
title_sort Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)
author Dourado, Marília
author_facet Dourado, Marília
Bento, Joana
Mesquita, Luis
Marques, Alcide
Vale-Pereira, Sofia
Sarmento-Ribeiro, Ana Bela
Mota-Pinto, Anabela
author_role author
author2 Bento, Joana
Mesquita, Luis
Marques, Alcide
Vale-Pereira, Sofia
Sarmento-Ribeiro, Ana Bela
Mota-Pinto, Anabela
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dourado, Marília
Bento, Joana
Mesquita, Luis
Marques, Alcide
Vale-Pereira, Sofia
Sarmento-Ribeiro, Ana Bela
Mota-Pinto, Anabela
dc.subject.por.fl_str_mv Granzimas
Sarcoidose
topic Granzimas
Sarcoidose
description Sarcoidosis is a systemic disease of unknown aetiology, morphologically characterized by well-formed epithelioid granulomas, which show little or no central necrosis. These may be present in any organ or tissue. The lung is the most frequently and prominently involved target. The granuloma is often very sharply demarcated from the adjacent tissue and is surrounded by a mantle of lymphocytes, which mediate lysis of target cells by various mechanisms, including exocytosis of lytic proteins, perforins and granzymes. Sarcoidosis laboratorial diagnosis is usually made by SACE and Lisozyme dosages. The granzymes A and B could be two other markers of the disease, since the sarcoidosis granuloma is rich in cytotoxic and NK cells. An ELISA Kit was used to measure Granzyme A and B in serum of a normal control group (NC) (n=30), and in two groups with lung pathology: one without sarcoidosis, disease control (DC) (n=21) and other with sarcoidosis (S) (n=11). Our results showed that SACE activity is significantly augmented in S group comparing with NC and DC, respectively: 82,6+/-32,7/31,9+/-17,8 - p=0,00017 and 82,6+/-32,7/31,9+/-17,8 - p=0,00024. Lisozyme activity is significantly augmented in S and DC groups comparing with NC. Granzyme B showed a significant decrease in DC and S groups comparing with NC. Granzyme A showed a significant decrease between S/NC groups. Our results suggest that the decrease of Granzyme A and B in sarcoidotic patients could be related to an ineffective inflammatory local response related to the formation of sarcoidosis granulomas. More studies are needed, particularly in BAL.
publishDate 2005
dc.date.none.fl_str_mv 2005
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/20228
http://hdl.handle.net/10316/20228
https://doi.org/10.1016/s0873-2159(15)30495-5
url http://hdl.handle.net/10316/20228
https://doi.org/10.1016/s0873-2159(15)30495-5
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133709498056704